Filing Details
- Accession Number:
- 0001209191-22-060480
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-09 16:15:11
- Reporting Period:
- 2022-11-17
- Accepted Time:
- 2022-12-09 16:15:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1652724 | Lucira Health Inc. | LHDX | In Vitro & In Vivo Diagnostic Substances (2835) | 272491037 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1877741 | Ghazi Kashmolah | 1412 62Nd Street Emeryville CA 94608 | Ex Vp & Chief Quality Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-11-17 | 8,011 | $0.38 | 171,876 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-11-17 | 25,236 | $0.37 | 146,640 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Billionaire Hedge Funds
